Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Quality of Oral Anticoagulation with Vitamin K Antagonists in 'Real-World' Patients: Lessons from a Six Years Audit Study

Fernanda Leite, MD PhD, Ângela Leite, PhD, Sara Ferreira, MD, Jorge Coutinho, MD

Blood (2019) 134 (Supplement_1): 1159.

https://doi.org/10.1182/blood-2019-129382

Published: 2019

Journal Articles

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Michael J. Kovacs, MD, Marc Rodger, MDMSc, Philip S. Wells, MDMSc,FRCP, Shannon M. Bates, MD MSc, Clive Kearon, MB, PhD, Mark Blostein, MDFRCPC, Alejandro Lazo-Langner, MD MSc, Susan Kahn, MD, Sam Schulman, MD PhD FRCPC, Elham Sabri, MSc, Susan Solymoss, MD, Timothy Ramsay, PhD, Luljeta Pallaveshi, RN, BA, David Anderson, MD

Blood (2018) 132 (Supplement 1): 424.

https://doi.org/10.1182/blood-2018-99-109964

Published: 2018

Journal Articles

Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy

Lai Heng Lee, MBBS,FRCP, Ming Chai Kong, Isabelle Teo, Shun Wei Lim, Jin Shing Hon, Kelly Bee Ling Chng, Sing Lin Tee, Elicia Purnata, Clifton You Xuan Liew, Xin Hui Loh, Cui Mei Fong, Nirmali Ruth Sivapragasam, Yiong Huak Chan, Jiang Ming Fam, Heng Joo Ng, Marcus Eng Hock Ong, David Bruce Matchar

Blood (2017) 130 (Supplement 1): 3719.

https://doi.org/10.1182/blood.V130.Suppl_1.3719.3719

Published: 2017

Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2017) 130 (Supplement 1): 220.

https://doi.org/10.1182/blood.V130.Suppl_1.220.220

Published: 2017

Journal Articles

Initial Experience with 4-Factor PCC for the Reversal of Warfarin: Patterns of Use and Safety Outcomes

Colleen T. Morton, David J Dries, MD, Fatima Khan, MBBS

Blood (2014) 124 (21): 2867.

https://doi.org/10.1182/blood.V124.21.2867.2867

Published: 2014

Journal Articles

Outcomes in Pregnant Women Exposed to Low Molecular Weight Heparin.

Maria Teresa De Sancho, MD, Sana Khalid, College, Student

Blood (2009) 114 (22): 4168.

https://doi.org/10.1182/blood.V114.22.4168.4168

Published: 2009

Journal Articles

Dose-Escalated Low Molecular Weight Heparin Provides Effective Anticoagulation for Women with Mechanical Heart Valves during Pregnancy: A Single-Centre Experience.

John Quinn, Ruth Brooks, Fiona Walker, Donald Peebles, Hannah Cohen

Blood (2007) 110 (11): 1873.

https://doi.org/10.1182/blood.V110.11.1873.1873

Published: 2007

Journal Articles

Results of a One-Year Registry of Bleeding Complications of Vitamin K Antagonist Therapy outside of a Controlled Population.

Kai M. Halbritter, Jan Beyer, Wolfram Oettler, Babett Kleinstück, Sebastian M. Schellong

Blood (2006) 108 (11): 4121.

https://doi.org/10.1182/blood.V108.11.4121.4121

Published: 2006

Journal Articles

Suspension of Vitamin K Antagonists Is Not Required for Cataract Surgery: A Prospective Study in a Cohort of 135 Consecutive Patients on Long-Term Anticoagulant Therapy.

Berardino Pollio, MD, Giuseppe A. Demarie, MD, Patrizia Ocello, MD, Grazia Delios, MD, Marco Tucciarone, MD, Gabriele Aitoro, MD, Rossella Perna, MD, Stefano D’Ardia, MD, Marco Ladetto, MD, Luigi Bauchiero, MD, Mauro Girotto, MD

Blood (2006) 108 (11): 882.

https://doi.org/10.1182/blood.V108.11.882.882

Published: 2006

Journal Articles

Low Dose Prothrombin Complex Concentrates Reverse Oral Anticoagulation with Minimal Complications.

Catherine N. Bagot, MBBS, MD, MRCP, Jaimal Kothari, MBBS, MRCP, Raj K. Patel, MD, MRCP, MRCPath, Roopen Arya, PhD, FRCP, FRCPath

Blood (2006) 108 (11): 891.

https://doi.org/10.1182/blood.V108.11.891.891

Published: 2006

Journal Articles

Recombinant Activated Factor VII (rFVIIa)-Mediated Normalization of INR Levels Post-Coumadin Overdose.

Wahid T. Hanna, MD

Blood (2005) 106 (11): 4102.

https://doi.org/10.1182/blood.V106.11.4102.4102

Published: 2005

Journal Articles

Microangiopathic Hemolytic Anemia (MHA) Associated with Acute Rheumatic Valvulitis.

Vinay Gudena, MD, James Schmotzer, MD, Milan Dopriak, MD, Robert Novoa, MD, Richard Morgan, MD

Blood (2004) 104 (11): 3679.

https://doi.org/10.1182/blood.V104.11.3679.3679

Published: 2004

NARROW

Quality of Oral Anticoagulation with Vitamin K Antagonists in 'Real-World' Patients: Lessons from a Six Years Audit Study

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Initial Experience with 4-Factor PCC for the Reversal of Warfarin: Patterns of Use and Safety Outcomes

Outcomes in Pregnant Women Exposed to Low Molecular Weight Heparin.

Dose-Escalated Low Molecular Weight Heparin Provides Effective Anticoagulation for Women with Mechanical Heart Valves during Pregnancy: A Single-Centre Experience.

Results of a One-Year Registry of Bleeding Complications of Vitamin K Antagonist Therapy outside of a Controlled Population.

Suspension of Vitamin K Antagonists Is Not Required for Cataract Surgery: A Prospective Study in a Cohort of 135 Consecutive Patients on Long-Term Anticoagulant Therapy.

Low Dose Prothrombin Complex Concentrates Reverse Oral Anticoagulation with Minimal Complications.

Recombinant Activated Factor VII (rFVIIa)-Mediated Normalization of INR Levels Post-Coumadin Overdose.

Microangiopathic Hemolytic Anemia (MHA) Associated with Acute Rheumatic Valvulitis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only